Fisher & Paykel Healthcare Corporation Limited FSPKF
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 274.83M | 263.15M | 256.02M | 239.73M | 222.90M |
| Total Depreciation and Amortization | 87.72M | 84.63M | 82.86M | 81.27M | 79.45M |
| Total Amortization of Deferred Charges | 5.35M | 4.37M | 3.53M | 3.53M | 3.53M |
| Total Other Non-Cash Items | 11.25M | 4.45M | -1.50M | 10.41M | 22.32M |
| Change in Net Operating Assets | 9.25M | -1.56M | -12.40M | -8.04M | -3.71M |
| Cash from Operations | 388.40M | 355.04M | 328.51M | 326.90M | 324.48M |
| Capital Expenditure | -101.06M | -75.13M | -50.52M | -47.22M | -43.78M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.14M | -13.37M | -13.86M | -15.69M | -17.48M |
| Cash from Investing | -114.20M | -88.50M | -64.38M | -62.91M | -61.25M |
| Total Debt Issued | 52.50M | 59.65M | 66.80M | 86.80M | 106.80M |
| Total Debt Repaid | -81.10M | -93.35M | -105.60M | -143.90M | -182.20M |
| Issuance of Common Stock | 4.20M | 4.10M | 4.00M | 3.55M | 3.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -131.51M | -126.98M | -124.38M | -112.07M | -99.50M |
| Other Financing Activities | -28.40M | -32.75M | -37.09M | -32.40M | -27.70M |
| Cash from Financing | -162.63M | -163.35M | -166.53M | -163.16M | -159.31M |
| Foreign Exchange rate Adjustments | 1.36M | 3.20M | 5.12M | 3.03M | 951.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 112.93M | 106.38M | 102.73M | 103.86M | 104.87M |